Myriad Genetics Fourth Quarter 2023 Financial Earnings

02/27/2024 | 1:30pm PST / 4:30pm EST

To participate in the live conference call via telephone, please register here

Events & Presentations

  • Myriad Genetics Fourth Quarter 2023 Financial Earnings

    02/27/2024 | 1:30pm PST / 4:30pm EST

    To participate in the live conference call via telephone, please register here

  • 42nd Annual J.P. Morgan Healthcare Conference

    01/11/2024 | 4:30pm PST / 7:30pm EST

  • Stephens Annual Investment Conference | NASH2023

    11/15/2023 | 11:00am PST / 2:00pm EST

Financial Reports and Filings

Date Filing Title Downloads
02/26/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
02/26/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
02/14/2024 SC 13G/A An amendment to the SC 13G filing RTF XLS PDF HTML XBRL
02/14/2024 SC 13G/A An amendment to the SC 13G filing RTF XLS PDF HTML XBRL
02/13/2024 SC 13G/A An amendment to the SC 13G filing RTF XLS PDF HTML XBRL
02/08/2024 SC 13G/A An amendment to the SC 13G filing RTF XLS PDF HTML XBRL
01/31/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
01/29/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
01/29/2024 3 Initial filing by director officer or owner of more than ten percent RTF XLS PDF HTML XBRL
01/24/2024 SC 13G/A An amendment to the SC 13G filing RTF XLS PDF HTML XBRL

Latest News

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 Thumbnail

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Feb 21, 2024 | Financial | Corporate

Read more
Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health Thumbnail

Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health

Feb 15, 2024 | Corporate | Products

Read more
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics Thumbnail

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Feb 01, 2024 | Corporate

Read more

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics